These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7559076)
1. Frequent amplification of the cyclin E gene in human gastric carcinomas. Akama Y; Yasui W; Yokozaki H; Kuniyasu H; Kitahara K; Ishikawa T; Tahara E Jpn J Cancer Res; 1995 Jul; 86(7):617-21. PubMed ID: 7559076 [TBL] [Abstract][Full Text] [Related]
2. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283 [TBL] [Abstract][Full Text] [Related]
3. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318 [TBL] [Abstract][Full Text] [Related]
4. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862 [TBL] [Abstract][Full Text] [Related]
5. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888 [TBL] [Abstract][Full Text] [Related]
6. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583 [TBL] [Abstract][Full Text] [Related]
7. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Kurzrock R; Ku S; Talpaz M Cancer; 1995 Jan; 75(2):584-90. PubMed ID: 7812927 [TBL] [Abstract][Full Text] [Related]
8. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766 [TBL] [Abstract][Full Text] [Related]
9. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Gillett C; Fantl V; Smith R; Fisher C; Bartek J; Dickson C; Barnes D; Peters G Cancer Res; 1994 Apr; 54(7):1812-7. PubMed ID: 8137296 [TBL] [Abstract][Full Text] [Related]
10. Expression of cyclins D1 and E in human colon adenocarcinomas. Sutter T; Doi S; Carnevale KA; Arber N; Weinstein IB J Med; 1997; 28(5-6):285-309. PubMed ID: 9604788 [TBL] [Abstract][Full Text] [Related]
11. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer. Zhang XM; Zhou C; Gu H; Yan L; Zhang GY Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233 [TBL] [Abstract][Full Text] [Related]
12. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Naitoh H; Shibata J; Kawaguchi A; Kodama M; Hattori T Am J Pathol; 1995 May; 146(5):1161-9. PubMed ID: 7747810 [TBL] [Abstract][Full Text] [Related]
13. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Jiang W; Zhang YJ; Kahn SM; Hollstein MC; Santella RM; Lu SH; Harris CC; Montesano R; Weinstein IB Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9026-30. PubMed ID: 8415648 [TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Nishida N; Fukuda Y; Komeda T; Kita R; Sando T; Furukawa M; Amenomori M; Shibagaki I; Nakao K; Ikenaga M Cancer Res; 1994 Jun; 54(12):3107-10. PubMed ID: 8205525 [TBL] [Abstract][Full Text] [Related]
15. Amplification and overexpression of cyclin D1 in aggressive human esophageal cancer. Inomata M; Uchino S; Tanimura H; Shiraishi N; Adachi Y; Kitano S Oncol Rep; 1998; 5(1):171-6. PubMed ID: 9458316 [TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of cyclin D1 messenger RNA expression in head and neck squamous cell carcinomas. Monden N; Nishizaki K; Fukushima K; Masuda Y; Tsukuda K; Shimizu K Jpn J Cancer Res; 1997 Jul; 88(7):660-8. PubMed ID: 9310139 [TBL] [Abstract][Full Text] [Related]
17. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance. Gao P; Zhou GY; Liu Y; Li JS; Zhen JH; Yuan YP World J Gastroenterol; 2004 Oct; 10(20):2936-9. PubMed ID: 15378768 [TBL] [Abstract][Full Text] [Related]
19. [Types of primary cyclins expressed in gastric carcinoma and their relationship with clinicopathological features]. Li WH; Wu JH; Gao C; Gong JP Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):114-8. PubMed ID: 23714665 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]